How, when, and where to utilize erlotinib, afatinib, and gefitinib in EGFR positive NSCLC
In this presentation from the 21st Annual Perspectives in Thoracic Oncology, Dr. Vera Hirsh discusses how, when, and where to utilize erlotinib, afatinib, and gefitinib in EGFR-positive non-small cell...
Author: imedex
Added: 05/05/2017
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts